Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma.

MLA

Csomor, Judit, et al. “Prolonged Survival Using Anti-CD20 Combined Chemotherapy in Primary Prostatic Intravascular Large B-Cell Lymphoma.” Pathology Oncology Research : POR, vol. 14, no. 3, Sept. 2008, pp. 281–84. EBSCOhost, https://doi.org/10.1007/s12253-008-9051-y.

APA

Csomor, J., Kaszás, I., Kollár, B., Pajor, L., Egyházi, Z., Fekete, S., Egyed, M., & Timár, B. (2008). Prolonged survival using anti-CD20 combined chemotherapy in primary prostatic intravascular large B-cell lymphoma. Pathology Oncology Research : POR, 14(3), 281–284. https://doi.org/10.1007/s12253-008-9051-y

Chicago

Csomor, Judit, Ilona Kaszás, Balázs Kollár, László Pajor, Zsolt Egyházi, Sándor Fekete, Miklós Egyed, and Botond Timár. 2008. “Prolonged Survival Using Anti-CD20 Combined Chemotherapy in Primary Prostatic Intravascular Large B-Cell Lymphoma.” Pathology Oncology Research : POR 14 (3): 281–84. doi:10.1007/s12253-008-9051-y.